PHARMA EXPORT: COMFORTS AND CONFRONTS IN INDIA

Authors

  • Alamelu R SASTRA University
  • Amudha R SASTRA University
  • CRESENTA SHAKILA MOTHA L SASTRA University
  • Nalini R SASTRA University

Abstract

ABSTRACT
The objective of this study is to know the comforts and confronts faced by pharma companies in India. It is of case study approach and presented the
Indian pharma export advantages, the Government initiatives toward the export market, problems, the recent US trademark legislation issues, and the
opportunities in a nutshell. The predicted growth of Indian pharmaceutical market size is US$ 100 billion by 2025, because of spending habit of the
customer on health care and their awareness on health insurance. Indian companies have focused on export prospects in both formal and informal
markets globally. This approach has made the pharma industry to achieve US$ 45 billion by 2020 and aimed to position as sixth largest market among
the world. Keeping the high credibility of serving quality products in the complex market, India has gained a strong reputation among the global place.
Keywords: Indian pharmaceutical, Pharma export, US trademark legislation, Indian pharma initiatives.

References

REFERENCES

Pharmaceutical Exports from India. August; 2015. Available from:

http://www.ibef.org/exports/pharmaceutical-exportsfromIndia.

Alamelu R, Amudha R, Motha LC, Nalini R. Online pharma retail is a

promising/unpromising avenue: An Indian context. Asian J Pharm Clin

Res 2016;9(2). [In print].

Alamelu R, Motha LC, Amudha R, Badrinath V. Pharmaceutical

industry - Studious or spurious? - An Indian context. Res J Pharm Biol

Chem Sci 2015;6:847-53.

UBM India, the Indian arm of London-Based Media and Events

Company Report; 2015. Available from: http://www.ubmindia.in/

about-ubm. [Last accessed on 2016 Feb 12].

Pharmaceuticals. and Consolidated FDI Policy, Department of

Industrial Policy & Promotion (DIPP), Press Information Bureau

(PIB), Media Reports, Pharmaceuticals Export Promotion Council.

Available from: http://www.indiainbusiness.nic.in/newdesign/

index.php?param=industryservices_landing/347/1. [Last accessed on

Feb 12].

Available from; http://www.tradingeconomics.com/india/exports-ofpharmaceutical-products.

[Last accessed on 2016

Feb

.

Palnitkar U. Indian pharma companies need to tap unexplored markets to

boost revenues. September, 2014. Available from: http://www.businessstandard.com/content/b2b-pharma/indian-pharma-companies-needto-tap-unexplored-markets-to-boost-revenues-114090300435_1.html.

[Last

accessed on 2016

Feb

.

Commerce Ministry Takes Steps to Boost Pharma Exports; Sets

up Committee. July, 2015. Available from: http://www.articles.

economictimes.indiatimes.com/2015-07-05/news/64112187_1_

pharma-exports-pharmaceutical-exports-awareness-programmes. [Last

accessed on 2016 Feb 12].

Bhatia K. Current scenario and future challenges in pharma

segment. January, 2014. Available from: http://www.pharmabiz.

com/NewsDetails.aspx?aid=79940&sid=9. [Last accessed on

Feb 12].

Sen A. EU’s trademark law: India fears pharma exports will be hit.

January, 2016. Available from: http://www.thehindubusinessline.com/

economy/policy/eus-trademark-law-india-fears-pharma-exports-willbe-hit/article8175691.ece.

[Last accessed on 2016

Feb

.

Arun S, Krishnan V. New U.S. Rule a Blow to Indian Pharma Exporters.

February, 2016. Available from: http://www.thehindu.com/todayspaper/tp-business/new-us-rule-a-blow-to-indian-pharma-exporters/

article8185521.ece.

[Last accessed on 2016

Feb

.

Published

2016-07-01

How to Cite

Alamelu R, Amudha R, CRESENTA SHAKILA MOTHA L, and Nalini R. “PHARMA EXPORT: COMFORTS AND CONFRONTS IN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 4, July 2016, pp. 24-26, https://innovareacademics.in/journals/index.php/ajpcr/article/view/11569.

Issue

Section

Review Article(s)